EGFR and non-small cell lung carcinoma: OPN promotes acquired EGFR-TKIs resistance by upregulating integrin αVβ3 expression, which activates the downstream FAK/AKT and ERK signaling pathways to promote NSCLC cell proliferation (Fu et al., 2020).